Prevalence of cerebral microbleeds and other cardiovascular risk factors in elderly patients with acute ischemic stroke

Abstract

Background

Cerebral microbleeds are small, round dark-signal foci in the T2^*-weighted magnetic resonance imaging. They are encountered in cerebral amyloid angiopathy and hypertensive vasculopathy. Their prevalence is common in ischemic stroke and cerebral hemorrhage. The purpose of this study is to investigate the prevalence of CMBs and associated risk factors in the elderly patients with acute ischemic stroke.

Results

Cerebral microbleeds were significantly associated with the presence of hypertension (in the subgroup of recurrent stroke) and with hypercholesterolemia. There was a significant association between the number of the microbleeds and severity of white matter lesions as a higher number of microbleeds related to more severe white matter lesions. The microbleeds were more prevalent in the group of patients using antithrombotics.

Conclusion

Age, hypercholesterolemia, and the use of antithrombotics emerged as the most important associated risk factors for the presence of CMBs. On MRI, there was a significant association between the number of CMBs and severity of white matter lesions as a higher number of CMBs related to more severe white matter lesions.

Background

Cerebral microbleeds (CMB) were defined as small round dark-signal lesions encountered by T2^*-weighted or gradient-echo (GRE) magnetic resonance imaging (MRI) [1]. These were presented to the clinical practice in the late 1990s and early 2000s after the evolution of MRI techniques sensitive to paramagnetic effects [2]. Histologically, they are tiny foci containing hemosiderin-laden macrophages in close spatial relation with abnormal blood vessels [3].

Two main types of vasculopathies have been linked with CMBs in the aging brain: cerebral amyloid angiopathy (CAA) and hypertensive vasculopathy (HV). CAA occurs as a result of the accumulation of β-amyloid on the vessel walls of cortical and leptomeningeal arteries, whereas HV is associated with long-standing hypertension and appears as lipofibrohyalinosis of the deep penetrating arterioles. Since both forms are associated with age, they may co-occur in a single person with different degrees of severity [4].

The clinical significance of CMBs has mainly been demonstrated in the light of cerebral hemorrhage and ischemic stroke, as their prevalence is common in both conditions [5]. They are considered as a marker of future stroke risk [6]. In addition, they have an independent association with cognitive dysfunction [7].

The reported prevalence of CMBs in ischemic stroke patients differs considerably {35–71%} [8–13]. This may be attributed to the heterogeneity of ischemic stroke per se or to differences in studied populations. Ethnicity may play a role in the prevalence of CMB.

The purpose of this study is to investigate the prevalence of CMBs and associated risk factors in the elderly patients with acute ischemic stroke.

Methods

Patients

The study was approved by the local institutional review board.

A retrospective study of elderly patients presented with acute ischemic stroke (primary or recurrent), in the period between January 2017 and December 2018, was conducted in Ain Shams University Hospitals which is one of the biggest tertiary hospitals in Cairo. The collected patient’s data included the following:

• Age and sex

• History of vascular risk factors including hypertension, diabetes mellitus, atrial fibrillation, hypercholesterolemia, and smoking

• History of antithrombotic treatment (antiplatelets or anticoagulants)

• Brain MRI and cerebral MRA (magnetic resonance angiography) findings

Ischemic stroke was classified according to the criteria of the National Institute of Neurologic Disorders and Stroke [14] as atherothrombotic infarction, cardio-embolic infarction, and lacunar infarction.

Inclusion criteria:

• Age ≥ 60 years

• No sex predilection

• Acute ischemic stroke presentation

Exclusion criteria:

• Age less than 60 years

• Cases of undetermined stroke subtype

• Patients with no or poor quality MR images

MR imaging sequences and interpretation

Brain MRI examinations were performed on a superconducting 1.5 T unit (Achieva; Philips Medical Systems, Best, the Netherlands).

All patients were scanned using standard stroke protocol with a dedicated head coil. The pulse sequences included:

• Axial T1-weighted (T1W) images (fast spin-echo sequence): repetition time (TR) = 597 ms, echo time (TE) = 15 ms, number of excitations (NEX) 2, flip angle 90, matrix 137 × 208 with a field of view (FOV) 230 (AP) × 186 (RL) × 131 (FH) mm, slice thickness 5 mm, and gap 0 mm.

• Axial T2-weighted (T2W) images (fast spin-echo sequence): TR = 4845 ms, TE = 110 ms, NEX 2, flip angle 90, matrix 147 × 256 with FOV 230 (AP) × 183 (RL) × 131 (FH) mm, slice thickness 5 mm, and gap 0 mm.

• Axial FLAIR (fluid-attenuated inversion recovery) images: TI (inversion time) = 2800 ms, TR = 11000 ms, TE = 130 ms, NEX 2, flip angle 90, matrix 137 × 208 with FOV 230 (AP) × 184 (RL) × 131 (FH) mm, slice thickness 5 mm, and gap 0 mm.

• Axial diffusion-weighted (DW) images: TR = 3724 ms, TE = 117 ms, b value = 0 and 1000 s/mm², matrix 105 × 136 with FOV 232 (AP) × 202 (RL) × 131 (FH) mm, slice thickness 5 mm, and gap 0 mm.

• Axial T2*-weighted (T2*W) images: TR = 691 ms, TE = 23 ms, matrix 133 × 208 with FOV 230 (AP) × 184 (RL) × 131 (FH) mm, slice thickness 5 mm, and gap 0 mm.

• Time of flight MRA of the circle of Willis.

The MR images were analyzed by 3 neuro-radiologists who were blinded to the old radiological reports.

Acute ischemic stroke was evident on the DWI as an area of diffusion restriction with corresponding low signal on the ADC map (Fig. 1).

Fig. 1 [Images not available. See PDF.]

Recurrent atherothrombotic stroke in a 70-year-old male. There is a recent right occipital infarction evident by restricted diffusion in the DWI (b = 1000 s/mm²) (a) with corresponding low signal on the ADC map (b). Higher cuts reveal an old right posterior parietal infarction showing dark signal on the DWI (c) with high signal on the ADC map (d) denoting facilitated diffusion. Time of flight cerebral MRA (maximum intensity projection-MIP) (e) shows diffuse atherosclerotic changes of the cerebral arteries expressed by vessels beading, attenuation, and reduced peripheral branching

Old strokes were depicted as gliotic/malacetic areas showing bright T2WI signal and low T1WI+/− FLAIR signal with no diffusion restriction and high signal on the ADC map (Fig. 1). Patients with old strokes were sub-grouped as recurrent strokes.

T2 GRE images were analyzed for the presence or absence of cerebral micro-bleeds. The grading scale of Lee et al. [15] was used [Fig. 2] which is summarized in Table 1.

Fig. 2 [Images not available. See PDF.]

Sequential cuts of T2*WI showing several dark signal foci of blooming scattered in both hemispheres representing grade 2 microbleeds

Table 1. Grading of cerebral micro-bleeds

Grade	Number of microbleeds
0	0
1 (mild)	1–2
2 (moderate)	3–10
3 (severe)	> 10

White matter FLAIR hyperintensities (leukoaraiosis) were graded using the scoring system prescribed by Fazekas et al. [16] as grade 0, absent; grade 1, punctate white matter foci; grade 2, early confluent lesions; and grade 3, confluent lesions (Fig. 3).

Fig. 3 [Images not available. See PDF.]

Axial FLAIR in two different patients showing grade 1 (a) and grade 3 (b) white matter hyperintensities according to Fazeka’s grading

Baseline characteristics, stroke subtypes, and severity of white matter lesions were compared between patients with and without CMBs.

Statistical methods

IBM SPSS statistics (V. 25.0, IBM Corp., USA, 2017–2018) was used for data analysis. The date was expressed as mean ± SD for quantitative parametric measures in addition to both number and percentage for categorized data.

The following tests were done:

1. Comparison between two independent mean groups for parametric data using Student t test.

2. Chi-square test to study the association between each 2 variables or comparison between 2 independent groups as regards the categorized data.

3. One-way ANOVA test (#post hoc test)

The probability of error at < 0.05 was considered statistically significant

Results

A total of 374 elderly patients (198 males and 176 females) with acute ischemic stroke were included in the study. Their age ranged from 60 to 93 years (mean age 68, ± 6.772 SD). 52.9% were males and 47.1% were females. Among the cardiovascular risk factors, dyslipidemia had the highest prevalence (65.85%) in the studied patients.

Table 2 shows the baseline characteristics of the study population.

Table 2. Baseline characteristics of the study population

Baseline characteristic	Number of patients (n = 374), n (%)
Sex
Male	198 (52.9%)
Female	176 (47.1%)
Mean age(range, years)	68 (60-93)
Hypertension	230 (61.5%)
Diabetes mellitus	188 (50.3%)
Hyperlipidemia	264 (65.8%)
Atrial fibrillation	30 (8%)
Smoking	80 (21.3%)
Old stroke	212 (56.7%)
Stroke subtypes
Atherothrombotic infarction	236 (63.3%)
Cardioembolic infarction	22 (5.8%)
Lacunar infarction	116 (31%)
CMBs
Absent	110 (29.4%)
Grade 1	264 (70.6%)
Grade 2	78 (20.9%)
Grade 3	16 (4.3%)
Location of microbleeds
Cortico-subcortical region	58 (51.8%)
Deep and infratentorial region	40 (35.7%)
Cortico-subcortical and deep	14 (12.5%)
Fazekas score
0	54 (14.4%)
1	116 (31 %)
2	132 (35.3%)
3	72 (19.3%)
Antithrombotic use	112 (29.9%)
Antiplatelets	88
Anticoagulant	24

The prevalence of CMBs among all the participants was found to be 29.4% (110/374 patients).

As shown in Table 3, the grade of microbleeds is significantly associated with older age (P = 0.03).

Table 3. Relation between age and grade of microbleeds

		Age		Fa	P value
		Mean	SD
Microbleeds grade	1.00	68.18	6.06	3.87	0.03
	2.00	72.25b	8.58
	3.00	63.62b	3.70

^aOne-way ANOVA test (^bpost hoc test)

CMBs were also significantly associated with the presence of hypertension in the subgroup of recurrent stroke (P = 0.04) but not in patients with primary stroke (P = 0.17), as described in Tables 4 and 5.

Table 4. Relation between hypertension and the presence of microbleeds in patients with primary stroke

		Microbleeds				Chi-square test	P value
		Positive		Negative
		N	%	N	%
Hypertension	Negative	20	50.0	40	32.8	1.91	0.17
	Positive	20	50.0	82	67.2

Table 5. Relation between hypertension and the presence of microbleeds in patients with recurrent stroke

		Microbleeds				Chi-square test	P value
		Positive		Negative
		N	%	N	%
HTN	Negative	18	25.7	66	46.5	4.23	0.04
	Positive	52	74.3	76	53.5

In our study population, CMBs showed significant association with hypercholesterolemia (P < 0.001) (Table 6).

Table 6. Relation between dyslipidemia and the presence of microbleeds

			Microbleeds.gr		Total
			Negative	Positive
Hypercholesterolemia	−	Count	44	84	128
		%	16.7%	76.4%	34.2%
	+	Count	220	26	246
		%	83.3%	23.6%	65.8%
Total		Count	264	110	374
		%	100.0%	100.0%	100.0%
Chi-square tests
		Value	P
Pearson chi-square		61.461	< 0.001

There was no significant association between the presence of microbleeds and stroke subtypes nor recurrent stroke (Table 7).

Table 7. Relation between stroke subtype and the presence of microbleeds

		Microbleeds				X2	P value
		Positive		Negative
		N	%	N	%
Stroke subtype	Atherothrombotic	68	61.8	168	63.6	1.48	0.48
	Lacunar	32	29.1	84	31.8
	Embolic	10	9.1	12	4.5

CMBs were found to occur more frequently in deep brain areas in hypertensive patients (P < 0.001) as demonstrated in Table 8.

Table 8. Relation between hypertension and site of microbleeds

		Site of microbleeds						Chi-square test	P value
		Lobar		Deep		Mixed
		N	%	N	%	N	%
Hypertension	Negative	38	65.5	0	0.0	0	0.0	28.77 FE	< 0.001
	Positive	20	34.5	40	100.0	14	100.0

There was a significant association between the number of CMBs and severity of white matter lesions as a higher number of CMBs related to more severe white matter lesions (P< 0.001), as shown in Table 9.

Table 9. Correlation between number of CMBs and severity of white matter lesions

			Microbleeds’ grade				Total
			0	1	2	3
Fazekas score	0	Count	46	8	0	0	54
		%	17.4%	10.3%	0.0%	0.0%	14.4%
	1	Count	88	26	2	0	116
		%	33.3%	33.3%	12.5%	0.0%	31.0%
	2	Count	86	36	6	4	132
		%	32.6%	46.2%	37.5%	25.0%	35.3%
	3	Count	44	8	8	12	72
		%	16.7%	10.3%	50.0%	75.0%	19.3%
Total		Count	264	78	16	16	374
		%	100.0%	100.0%	100.0%	100.0%	100.0%
Chi-square tests
		Value		P
Pearson chi-square		28.031		< 0.001

The microbleeds were more prevalent in the group of patients using antithrombotics (P < 0.001) (Table 10).

Table 10. Relation between the use of antithrombotic and the presence of microbleeds

		Microbleeds				Chi-square test	P value
		Positive		Negative
		N	%	N	%
Antithrombotic treatment	Negative	10	9.1	252	95.5	138.3	< 0.001
	Positive	100	90.9	12	4.5

Discussion

With the widespread of MRI in stroke patients, CMBs have been commonly encountered which emphasized considerable prevalence and significance of CMBs in the aging population [17]. As the prevalence of CMBs varies tremendously depending on the MRI study characteristics and the selection of the study population, the reported prevalence in different clinical conditions has greatly broad ranges: 47 to 80% in intracranial hemorrhage [10, 18], 18 to 71% [9, 19] in ischemic stroke, or 17 to 46% in cognitive decline/dementia [20]. On the other hand, several population-based studies have also reported CMB prevalence in subjects without a history of cerebrovascular disease to be between 3 and 7% [21–23].

In the present study, the prevalence of CMBs was found to be 29.4% in the Egyptian elderly with acute ischemic stroke which is lower than reported by Koennecke HC [5] (40%) but close to a report from a Chinese study that found prevalence of CMBs to be 24% in Chinese patients with ischemic stroke [24].

Several studies reported that the prevalence of CMBs increased with age in adult participants without stroke [5, 23]. In our study, we found that the grade of microbleeds is significantly associated with older age.

In our study population, 61.5% were hypertensive. Despite this, we did not find a significant association of hypertension with CMBs except in the subgroup of recurrent stroke.

In several studies, hypertension has not steadily been found to be associated with microbleeds. Jeerakathil et al. [8] found an association between microbleeds and hypertension which disappeared after the correction for age and sex. In patients with ischemic stroke, microbleeds were associated with chronic hypertension in some studies, but others did not confirm this association [25].

In the present study, CMBs were found to occur more frequently in deep brain areas in hypertensive patients. Several pathologic studies have observed that hypertensive angiopathy is predominantly noted in deep or infratentorial brain areas, while amyloid angiopathy is commonly situated in cerebral lobar regions [25]. Furthermore, other population-based observational studies have shown that hypertension or elevated blood pressure [26, 27] was associated with deep/infratentorial CMBs. These findings are in line with ours.

Intriguingly, a study by Lee et al. [28] investigating microbleeds in 129 hypertensive patients noted microbleeds to occur more frequently in the cortico-subcortical region.

The Rotterdam Scan Study has showed significant association of very low serum cholesterol levels (< 4.42 mmol/L versus higher values) with the presence of strictly lobar microbleeds [27], whereas Yubi et al. [29] noted that lower total cholesterol levels were associated with the presence of deep/infratentorial CMBs in the Japanese elderly. In contrast, in our study, we found a significant association of hypercholesterolemia and the presence of microbleeds. The exact reason for the inconsistency between Japanese and Western studies and our study is unknown but may be due to dissimilarity in the genetic backgrounds, the age distributions, and lifestyles [26].

On the other hand, our study findings are in line with Ni R et al. [30] who reported an association of multiple CMBs with white matter hyperintensities (WMH), dyslipidemia, hyperhomocysteine, and uric acid.

50.3% of our patients were diabetics. However, no significant associations have been found between CMBs and diabetes in our study participants. Association between CMBs and diabetes has been inconsistent across published reports [31].

In ischemic stroke, CMBs are more commonly reported in patients with small vessel disease ischemic stroke than in individuals having large vessel stroke (atherothromboembolic or cardioembolic) [32]. Kato et al. [19] reported a greater prevalence of CMBs in subjects with lacunar infarct (62%) than those with cardioembolic infarct (30%) and atherothrombotic infarct (21%) in a study which included 213 patients with ischemic stroke. However, another study from Japan noted that CMBs were associated with atherothrombotic (5/22, 23%) and lacunar (7/31, 23%) but not in cardioembolic stroke (0/13, 0%) [17].

In our study, we did not find a significant association between the presence of CMBs and stroke subtype.

Our study revealed an association between the number of CMBs and the severity of white matter lesions as a higher number of CMBs related to more severe white matter lesions. A relationship between CMBs and severity of white matter hyperintensities, or leukoaraiosis, has been reported in ischemic and hemorrhagic stroke patients [33–35], Alzheimer’s dementia [36–38], vascular dementia [33], and community-dwelling elderly [23, 39]. These findings indicate that the detection of microbleeds reflects advanced stage of microangiopathy in which the blood vessels are prone to bleeding.

The association of antithrombotic treatment and prevalence of CMBs is still debated as some studies reported the relationship but not in others [24]. In our study, we observed that microbleeds were more prevalent in the group of patients using antithrombotics.

As a part of self-criticism, our study is limited as we included patients from only one tertiary referral center that covers a limited geographical area in Egypt. Future work including a bigger sample from a greater geographic area or be expanded to a multi-government analysis is encouraged.

Conclusion

The present study is the first observational study to explore the prevalence of CMBs and associated risk factors in Egyptian elderly with acute ischemic stroke.

In our study, we found that the prevalence of microbleeds is 29.4% (110/374 patients) in the elderly population of patients suffering from ischemic stroke. Age, hypercholesterolemia, and use of antithrombotics emerged as the most important associated risk factors for the presence of CMBs. On MRI, there was a significant association between the number of CMBs and severity of white matter lesions as a higher number of CMBs related to more severe white matter lesions.

Further prospective studies are required to define the risk factors for the development of CMBs and to set strategies for prevention of CMBs and consequent neurologic disorders including symptomatic stroke and dementia.

Acknowledgements

Not applicable

Authors’ contributions

AI suggested and developed the research idea, shared in reviewing the literature and data analysis, and wrote the manuscript. YI contributed to the data collection and analysis and manuscript editing. ED contributed to the data collection and analysis and prepared the figures and tables. NK contributed to the data collection and analysis and reviewing the literature. All authors read and approved the final manuscript.

Funding

Not applicable

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Ethics approval and consent to participate

The local ethics committee of Ain Shams University ruled that no formal ethics approval was required in this retrospective study. However, non-formal IRB approval was obtained.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Abbreviations

CAA

Cerebral amyloid angiopathy

CMB

Cerebral microbleeds

GRE

Gradient echo

HV

Hypertensive vasculopathy

MRA

Magnetic resonance angiography

MRI

Magnetic resonance imaging

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

1. Greenberg, SM; Vernooij, MW; Cordonnier, C; Viswanathan, A; Al-Shahi Salman, R; Warach, S et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol; 2009; 8, pp. 165-174. [DOI: https://dx.doi.org/10.1016/S1474-4422(09)70013-4]

2. Offenbacher, H; Fazekas, F; Schmidt, R; Koch, M; Fazekas, G; Kapeller, P. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. Am J Neuroradiol; 1996; 17, pp. 573-578.[COI: 1:STN:280:DyaK2s%2FjsFKjuw%3D%3D] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8881257]

3. Tanaka, A; Ueno, Y; Nakayama, Y; Takano, K; Takebayashi, S. Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke; 1999; 30, pp. 1637-1642.[COI: 1:STN:280:DyaK1MzmsFCmtA%3D%3D] [DOI: https://dx.doi.org/10.1161/01.STR.30.8.1637]

4. Fazekas, F; Kleinert, R; Roob, G; Kleinert, G; Kapeller, P; Schmidt, R; Hartung, HP. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. Am J Neuroradiol; 1999; 20, pp. 637-642.[COI: 1:STN:280:DyaK1M3ltFKqsQ%3D%3D] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10319975]

5. Koennecke, HC. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology; 2006; 66, pp. 165-171. [DOI: https://dx.doi.org/10.1212/01.wnl.0000194266.55694.1e]

6. Nishikawa, T; Ueba, T; Kajiwara, M; Fujisawa, I; Miyamatsu, N; Yamashita, K. Cerebral microbleeds predict first-ever symptomatic cerebrovascular events. Clin Neurol Neurosurg; 2009; 111, pp. 825-810. [DOI: https://dx.doi.org/10.1016/j.clineuro.2009.08.011]

7. Werring, DJ; Frazer, DW; Coward, LJ; Losseff, NA; Watt, H; Cipolotti, L et al. Cognitive dysfunction in patients with cerebral microbleeds on T2-weighted gradient-echo MRI. Brain; 2004; 127, pp. 2265-2275. [DOI: https://dx.doi.org/10.1093/brain/awh253]

8. Jeerakathil, T; Wolf, PA; Beiser, A; Hald, JK; Au, R; Kase, CS et al. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke; 2004; 35, pp. 1831-1835. [DOI: https://dx.doi.org/10.1161/01.STR.0000131809.35202.1b]

9. Kinoshita, T; Okudera, T; Tamura, H; Ogawa, T; Hatazawa, J. Assessment of lacunar hemorrhage associated with hypertensive stroke by echo-planar gradient-echo T2*-weighted MRI. Stroke; 2000; 31, pp. 1646-1650.[COI: 1:STN:280:DC%2BD3czksFWktw%3D%3D] [DOI: https://dx.doi.org/10.1161/01.STR.31.7.1646]

10. Tsushima, Y; Aoki, J; Endo, K. Brain microhemorrhages detected on T2*-weighted gradient-echo MR images. Am J Neuroradiol; 2003; 24, pp. 88-96. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12533332]

11. Lee, SH; Kwon, SJ; Kim, KS; Yoon, BW; Roh, JK. Cerebral microbleeds in patients with hypertensive stroke. Topographical distribution in the supratentorial area. J Neurol; 2004; 251, pp. 1183-1189. [DOI: https://dx.doi.org/10.1007/s00415-004-0500-6]

12. Lee, SH; Kwon, SJ; Kim, KS; Yoon, BW; Roh, JK. Topographical distribution of pontocerebellar microbleeds. Am J Neuroradiol; 2004; 25, pp. 1337-1341. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15466328]

13. Imaizumi, T; Horita, Y; Chiba, M; Hashimoto, Y; Honma, T; Niwa, J. Dot-like hemosiderin spots on gradient echo T2*-weighted magnetic resonance imaging are associated with past history of small vessel disease in patients with intracerebral hemorrhage. J Neuroimaging; 2004; 14, pp. 251-257. [DOI: https://dx.doi.org/10.1111/j.1552-6569.2004.tb00247.x]

14. (1990) Special Report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 21:637–676

15. Lee, SH; Bae, HJ; Yoon, BW; Kim, H; Kim, DE; Roh, JK. Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions. Stroke; 2002; 33, pp. 2845-2849.[COI: 1:CAS:528:DC%2BD38XptVShtrs%3D] [DOI: https://dx.doi.org/10.1161/01.STR.0000036092.23649.2E]

16. Fazekas, F; Chawluk, JB; Alavi, A; Hurtig, HI; Zimmerman, RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol; 1987; 149, pp. 351-356.[COI: 1:STN:280:DyaL2s3mslWgsw%3D%3D] [DOI: https://dx.doi.org/10.2214/ajr.149.2.351]

17. Naka, H; Nomura, E; Wakabayashi, S; Kajikawa, H; Kohriyama, T; Mimori, Y; Nakamura, S; Matsumoto, M. Frequency of asymptomatic microbleeds on T2*-weighted MR images of patients with recurrent stroke: association with combination of stroke subtypes and leukoaraiosis. AJNR Am J Neuroradiol.; 2004; 25, pp. 714-719. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15140709]

18. Lee, SH; Bae, HJ; Kwon, SJ; Kim, H; Kim, YH; Yoon, BW; Roh, JK. Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology.; 2004; 62, pp. 72-76.[COI: 1:STN:280:DC%2BD2c%2FitF2ruw%3D%3D] [DOI: https://dx.doi.org/10.1212/01.WNL.0000101463.50798.0D]

19. Kato, H; Izumiyama, M; Izumiyama, K; Takahashi, A; Itoyama, Y. Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke.; 2002; 33, pp. 1536-1540. [DOI: https://dx.doi.org/10.1161/01.STR.0000018012.65108.86]

20. Cordonnier, C; van der Flier, WM; Sluimer, JD; Leys, D; Barkhof, F; Scheltens, P. Prevalence and severity of microbleeds in a memory clinic setting. Neurology.; 2006; 66, pp. 1356-1360.[COI: 1:STN:280:DC%2BD283lvVehsw%3D%3D] [DOI: https://dx.doi.org/10.1212/01.wnl.0000210535.20297.ae]

21. Tsushima, Y; Tanizaki, Y; Aoki, J; Endo, K. MR detection of microhemorrhages in neurologically healthy adults. Neuroradiology.; 2002; 44, pp. 31-36.[COI: 1:STN:280:DC%2BD383gvVSrsA%3D%3D] [DOI: https://dx.doi.org/10.1007/s002340100649]

22. Igase, M; Tabara, Y; Igase, K; Nagai, T; Ochi, N; Kido, T et al. Asymptomatic cerebral microbleeds seen in healthy subjects have a strong association with asymptomatic lacunar infarction. Circ J.; 2009; 73, pp. 530-533. [DOI: https://dx.doi.org/10.1253/circj.CJ-08-0764]

23. Poels, MM; Vernooij, MW; Ikram, MA; Hofman, A; Krestin, GP; van der Lugt, A et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam Scan Study. Stroke.; 2010; 41, pp. S103-S106. [DOI: https://dx.doi.org/10.1161/STROKEAHA.110.595181]

24. Tang, WK; Chen, YK; Lu, J; Ahuja, AT; Chu, WC; Mok, VC et al. Cerebral microbleeds and quality of life in acute ischemic stroke. Neurol Sci.; 2011; 32, pp. 449-454.[COI: 1:STN:280:DC%2BC3MrgtFyrtg%3D%3D] [DOI: https://dx.doi.org/10.1007/s10072-011-0571-y]

25. Cordonnier, C; Al-Shahi Salman, R; Wardlaw, J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain; 2007; 130, pp. 1988-2003. [DOI: https://dx.doi.org/10.1093/brain/awl387]

26. Romero, JR; Preis, SR; Beiser, A et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke; 2014; 45, pp. 1492-1494. [DOI: https://dx.doi.org/10.1161/STROKEAHA.114.004130]

27. Vernooij, MW; van der Lugt, A; Ikram, MA et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology; 2008; 70, pp. 1208-1214.[COI: 1:STN:280:DC%2BD1c3hvFOlsw%3D%3D] [DOI: https://dx.doi.org/10.1212/01.wnl.0000307750.41970.d9]

28. Lee, SH; Bae, HJ; Ko, SB; Kim, H; Yoon, BW; Roh, JK. Comparative analysis of the spatial distribution and severity of cerebral microbleeds and old lacunes. J Neurol Neurosurg Psychiatry; 2004; 75, pp. 423-427. [DOI: https://dx.doi.org/10.1136/jnnp.2003.015990]

29. Yubi, T; Hata, J; Ohara, T; Mukai, N; Hirakawa, Y; Yoshida, D et al. Prevalence of and risk factors for cerebral microbleeds in a general Japanese elderly community. Neurol Clin Pract; 2018; 8, 3 pp. 223-231. [DOI: https://dx.doi.org/10.1212/CPJ.0000000000000464]

30. Ni, R; Chu, L; Xu, D; Li, Y; Zhang, Y; You, M; Zhu, Y; Ouyang, F; Zhang, J; Cai, G; Lin, X; Yang, Z; Gao, Z. Risk factors of cerebral microbleeds in young and middle-aged patients with hypertension. Neurol Res; 2018; 40, 5 pp. 413-418. [DOI: https://dx.doi.org/10.1080/01616412.2018.1451268]

31. Kim, BJ; Lee, SH; Kang, BS; Yoon, BW; Roh, JK. Diabetes increases large artery diseases, but not small artery diseases in the brain. J Neurol; 2008; 255, pp. 1176-1181. [DOI: https://dx.doi.org/10.1007/s00415-008-0864-0]

32. Ovbiagele, B; Saver, JL; Sanossian, N; Salamon, N; Villablanca, P; Alger, JR et al. Predictors of cerebral microbleeds in acute ischemic stroke and TIA patients. Cerebrovasc Dis; 2006; 22, pp. 378-383. [DOI: https://dx.doi.org/10.1159/000094855]

33. Hanyu, H; Tanaka, Y; Shimizu, S; Takasaki, M; Fujita, H; Kaneko, N et al. Cerebral microbleeds in Binswanger’s disease: a gradient-echo T2*-weighted magnetic resonance imaging study. Neurosci Lett.; 2003; 340, pp. 213-216.[COI: 1:CAS:528:DC%2BD3sXisV2lsLY%3D] [DOI: https://dx.doi.org/10.1016/S0304-3940(03)00121-6]

34. Lee, S-H; Lee, S-T; Kim, BJ; Park, H-K; Kim, C-K; Jung, K-H et al. Dynamic temporal change of cerebral microbleeds: long-term follow-up MRI study. PLoS One; 2011; 6, 10 e25930.[COI: 1:CAS:528:DC%2BC3MXhtl2lsrrO] [DOI: https://dx.doi.org/10.1371/journal.pone.0025930]

35. Alemany, M; Stenborg, A; Terent, A; Sonninen, P; Raininko, R. Coexistence of microhemorrhages and acute spontaneous brain hemorrhage: correlation with signs of microangiopathy and clinical data. Radiology; 2006; 238, pp. 240-710. [DOI: https://dx.doi.org/10.1148/radiol.2381040551]

36. Pettersen, JA; Sathiyamoorthy, G; Gao, F-Q; Szilagyi, G; Nadkarni, NK; St George-Hyslop, P et al. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol; 2008; 65, 790. [DOI: https://dx.doi.org/10.1001/archneur.65.6.790]

37. Nakata-Kudo, Y; Mizuno, T; Yamada, K; Shiga, K; Yoshikawa, K; Mori, S et al. Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease. Dement Geriatr Cogn Disord; 2006; 22, 8. [DOI: https://dx.doi.org/10.1159/000092958]

38. Hanyu H, Tanaka Y, Shimizu S, Takasaki M, Abe K (2003) Cerebral microbleeds in Alzheimer’s disease. J Neurol 250

39. Takashima, Y; Mori, T; Hashimoto, M; Kinukawa, N; Uchino, A; Yuzuriha, T et al. Clinical correlating factors and cognitive function in community-dwelling healthy subjects with cerebral microbleeds. J Stroke Cerebrovasc Dis; 2011; 20, 105. [DOI: https://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2009.11.007]